Current progress in ABO-incompatible liver transplantation

European Journal of Clinical Investigation

Volumn 40, Issue 10, 2010, Pages 943-949

  Tanabe, Minoru ^a   Kawachi, Shigeyuki ^a   Obara, Hideaki ^a   Shinoda, Masahiro ^a   Hibi, Taizo ^a   Kitagawa, Yuko ^a   Wakabayashi, Go ^b   Shimazu, Motohide ^c   Kitajima, Masaki ^d  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d International University of Health and Welfare Mita Hospital   (Japan)

Author keywords

ABO incompatible; antibody mediated rejection; liver transplantation; living donor; rituximab

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GABEXATE MESILATE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PROSTAGLANDIN E1; RITUXIMAB; TACROLIMUS;

ANTIBODY MEDIATED REJECTION; BILIARY TRACT DISEASE; BLOOD GROUP ABO INCOMPATIBILITY; DRUG MEGADOSE; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; JAPANESE; KIDNEY DYSFUNCTION; LEUKOPENIA; LIVER GRAFT REJECTION; LIVER NECROSIS; LIVER TRANSPLANTATION; LUNG EDEMA; MORBIDITY; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BLOOD GROUP INCOMPATIBILITY; GRAFT REJECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; LIVER TRANSPLANTATION; LIVING DONORS; PORTAL VEIN; SPLENECTOMY;

EID: 77956554854     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02339.x     Document Type: Review

References (39)

1. Demetris AJ, Jaffe R, Tzakis A, Ramsey G, Todo S, Belle S et al. Antibody-mediated rejection of human orthotopic liver allografts A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988 132 : 489 502.
2. Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990 336 : 519 523.
3. Farges O, Kalil AN, Samuel D, Saliba F, Arulnaden JL, Debat P et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995 59 : 1124 1133.
4. Kiuchi T, Tanaka K. Living-related donor liver transplantation: Status Quo in Kyoto, Japan. Transplant Proc 1998 30 : 687 691.
5. Alexandre GPJ, Squiffl et JP, De Bruyere M, Latinne D, Morian M, Ikebu N et al. Splenectomy as a prerequisiste for successful human ABO-incompatible renal transplantation. Transplant Proc 1985 17 : 138 143.
6. Egawa H, Oike F, Buhler L, Shapiro AM, Minamiguchi S, Haga H et al. Impact of recipient age on outcome of ABO-incopatible living-donor liver transplantation. Transplantation 2004 77 : 403 411. (Pubitemid 38209740)
7. Toso C, Al-Qahtani M, Alsaif FA, Bigam DL, Meeberg GA, James Shapiro AM et al. ABO-incompatible liver transplantation for critically ill adult patients. Transpl Int 2007 20 : 675 681.
8. Pratschke J, Tullius SG. Promising recent data on ABO incompatible liver transplantation: restrictions may apply. Transpl Int 2007 20 : 647 648.
9. Takahashi K, Yagisawa T, Sonda K, Kawaguchi H, Yamaguchi Y, Toma H et al. ABO-incompatible kidney transplantation in a single-center trial. Transplant Proc 1993 25 : 271 273.
10. Saito K, Takahashi K. ABO-incompatible kidney transplantation. In : Takahashi K, Tanaka K, editors. New Strategies for ABO-incompatible Kidney Transplantation 2008. Tokyo : Nihon Igakukan 2008 : pp 3 17.
11. Toma H. ABO-incompatible renal transplantation. Urol Clin North Am 1994 21 : 299.
12. Tanabe M, Shimazu M, Wakabayashi G, Hoshino K, Kawachi S, Kadomura T et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002 73 : 1959 1961.
13. 1. Transplantation 1992 54 : 927 929.
14. Takenaka N, Shimada Y, Hirata T, Nishijima MK, Takezawa J, Yoshiya I et al. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis. Crit Care Med 1983 11 : 735.
15. The Japanese Liver Transplantation Society. Liver transplantation in Japan-registry by the Japanese Liver Transplantation Society (in Japanese with English abstract). Isyoku 2005 40 : 518 526.
16. Kozaki K, Egawa H, Kasahara M, Oike F, Yoshizawa A, Fukatsu A et al. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Ther Apher Dial 2005 9 : 285 291.
17. Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008 47 : 143 152.
18. Takahashi K. Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol 2007 11 : 128 141.
19. Takahashi K. A new concept of accommodation in ABO incompatible kidney transplantation. Clin Transplant 2005 19 (Suppl. 14 76 85.
20. Zecca M, De Stefano P, Nobili B, Locatelli F. Anti-CD20 monoclonal antibody for the treatment of severe, immunemediated, pure red cell aplasia and hemolytic anemia. Blood 2001 97 : 3995 3997.
21. Sawada T, Fuchimoto S, Teraoka S. Successful A1 to O, ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double filtration plasmapheresis. Transplantation 2002 74 : 1207 1210.
22. Gloor JM, DeGoey SR, Pineda AA, Moore SB, Prieto M, Nyberg SL et al. Overcoming a positive crossmatch in living-donor kidney transplantation Am J Transpl 2003 3 : 1017 1023.
23. Pierson RN III., Loyd JE, Goodwin A, Majors D, Dummer JS, Mohacsi P et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, compliment inhibition, and immunomodulatory therapy. Transplantation 2002 74 : 79 84.
24. Aranda JM, Scornik JC, Normann SJ, Lottenberg R, Schofield RS, Pauly DF et al. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 2002 73 : 907 910.
25. Egawa H. Japanese ABO-incompatible transplantation committee. Japanese registry of ABO-incompatible living-donor liver transplantation 2008. In : Takahashi K, Tanaka K, editors. New Strategies for ABO Incompatible Transplantation 2009. Tokyo : Nihon Igakukan, 2009 : 68 70.
26. Usuda M, Fujimori K, Koyamada N, Fukumori T, Sekiguchi S, Kawagishi N et al. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible livingrelated liver transplantation. Transplantation 2005 79 : 12 6.
27. Monteiro I, McLoughlin L, Fisher A, de la Torre AN, Koneru Baburao. Rituximab with plasmapheresis and splenectomy in ABO-incompatible liver transplantation. Transplantation 2003 76 : 1648 1649.
28. Egawa H, Ohmori K, Haga H, Tsuji H, Yurugi K, Miyagawa-Hayashino A et al. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transpl 2007 13 : 579 588.
29. Takahashi K. Effects and complications of splenectomy. In : Takahashi K, editor. Accommodation in ABO-incompatible Kidney Transplantation. Amsterdam : Elsevier 2004 Chap. 7: pp 81 3.
30. Mor E, Skerrett D, Manzarbeitia C, Sheiner PA, Schwartz M, Emre S et al. Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation 1995 59 : 986 990.
31. Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Harada N et al. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Transplantation 2009 88 : 303 307.
32. Jordan S, Cunningham-Rundles C, McEwan R. Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications. Am J Transplant 2003 3 : 653 664.
33. Urbani L, Mazzoni A, Bianco I, Grazzini T, De Simone P, Catalano G et al. The role of immunomodulation in ABO-incompatible adult liver transplant recipients. J Clin Apher 2008 23 : 55 62.
34. Tanaka K, Ozawa K, Teramukai S, Takada Y, Egawa H, Kaihara S et al. Classification of human liver transplant recipients by their preoperative CD8 cell subpopulation and its relation to outcome. Liver Transpl 2006 12 : 792 800.
35. Tanaka K, Uemoto S, Egawa H, Takada Y, Ozawa K, Teramukai S et al. Cytotoxic T-cell-medicated defense against infections in human liver transplant recipients. Liver Transpl 2007 13 : 287 293.
36. Egawa H, Ozawa K, Takada Y, Teramukai S, Mori A, Kasahara M et al. Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT. Dig Dis Sci 2009 54 : 2253 2263.
37. Ohdan H, Zhou W, Tanaka Y, Irei T, Fuchimoto Y, Egawa H et al. Evidence of immune tolerance to blood group antigens in a case of ABO-incompatible pediatric liver transplantation. Am J Transplant 2007 7 : 2190 2194.
38. Haga H, Egawa H, Shirase T, Miyagawa A, Sakurai T, Minamiguchi S et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl 2004 10 : 16 27.
39. Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl 2006 12 : 457 464.